|
MED17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.70579999999787E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.58260000238909E-08 |
| Normal-vs-Stage2 |
6.019200E-03 |
| Normal-vs-Stage3 |
3.739400E-01 |
| Normal-vs-Stage4 |
1.012420E-01 |
| Stage1-vs-Stage2 |
9.456800E-01 |
| Stage1-vs-Stage3 |
7.80060000000748E-05 |
| Stage1-vs-Stage4 |
1.565750E-02 |
| Stage2-vs-Stage3 |
2.882000E-02 |
| Stage2-vs-Stage4 |
1.203800E-01 |
| Stage3-vs-Stage4 |
3.887000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.582880E-04 |
| Normal-vs-AfricanAmerican |
1.521810E-03 |
| Normal-vs-Asian |
3.206100E-02 |
| Caucasian-vs-AfricanAmerican |
2.465400E-01 |
| Caucasian-vs-Asian |
5.863200E-01 |
| AfricanAmerican-vs-Asian |
9.378000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.319940E-03 |
| Normal-vs-Female |
1.49380000002974E-06 |
| Male-vs-Female |
3.131700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.741000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.50624999999405E-05 |
| Normal-vs-Age(61-80Yrs) |
8.207500E-04 |
| Normal-vs-Age(81-100Yrs) |
5.429000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.125000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.780600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.546200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.508230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.604360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.573800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.07259999992948E-07 |
| Normal-vs-Grade 2 |
4.89410001414115E-09 |
| Normal-vs-Grade 3 |
1.293770E-02 |
| Normal-vs-Grade 4 |
2.975000E-01 |
| Grade 1-vs-Grade 2 |
5.967700E-02 |
| Grade 1-vs-Grade 3 |
4.392800E-04 |
| Grade 1-vs-Grade 4 |
1.50031999999189E-05 |
| Grade 2-vs-Grade 3 |
1.179890E-04 |
| Grade 2-vs-Grade 4 |
2.13070000532056E-08 |
| Grade 3-vs-Grade 4 |
1.864250E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.06614758424939E-12 |
| Normal-vs-ccB subtype |
8.662600E-01 |
| ccA subtype-vs-ccB subtype |
4.14446255092571E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.644200E-04 |
| Normal-vs-N1 |
7.522200E-01 |
| N0-vs-N1 |
8.504000E-02 |
|
|
